Enhanced TLR2 responses in multiple sclerosis.

Clin Exp Immunol · 2018 · PMC6150258 · PMID 30043528

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not quite reach statistical significanceno p-value reported

The percentages of enhanced responses from patients with progressive forms of the disease (mean = 60·13%) was statistically greater than that of the controls (mean = 6·87%), while the percentages of enhanced responses among the total MS patients (mean = 51·55%) and the RRMS patients (mean = 41·65%) were also increased compared to the controls (6.87%), but did not quite reach statistical significance (Fig. 8 ).

also in 679 other papers

highly significantno p-value reported

We found that the differences in the proportion of responses above and below the threshold between controls and the total cohort of MS patients were highly significant (Fig. 7 a–c).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.